Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET (ACNS0332)

This collection contains data from the Children’s Oncology Group (COG) Clinical Trial NCT00392327, Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET, " Study Chair: James M. Olson, M.D., Ph.D. It was sponsored by NCI and performed by the Children's Oncology Group under study number ACSN0332. This randomized phase III trial studies different chemotherapy and radiation therapy regimens to compare how well they work in treating young patients with newly diagnosed, previously untreated, high-risk medulloblastoma.本数据集收录了来自儿童肿瘤学组（Children’s Oncology Group，简称COG）临床试验NCT00392327的相关数据，该试验的研究主题为"针对新确诊、既往未接受治疗的高危髓母细胞瘤/原始神经外胚层肿瘤（Primitive Neuroectodermal Tumor, PNET）青年患者的化疗与放射治疗"，研究首席负责人为詹姆斯·M·奥尔森医学博士、哲学博士。本试验由美国国家癌症研究所（National Cancer Institute, NCI）资助，由儿童肿瘤学组以试验编号ACSN0332组织实施。本项随机化III期临床试验旨在对比不同化疗与放射治疗方案，以评估其在治疗新确诊、既往未接受治疗的高危髓母细胞瘤青年患者中的疗效优劣。